Top Journalists
>
Isabella Hornick

Isabella Hornick

Author at healio.com at Healio

Contact this person
Email address
i*****@*******.comGet email address
Influence score
22
Location
United States
Languages
  • English
Covering topics

    View more media outlets and journalists by signing up to AI PR

    View latest data and reach out all from one place
    Sign up to AI PR Toolkit

    Recent Articles

    healio.com

    Asthma mortality falls, COPD, ILD mortality rises from 1990 to 2023 in US

    In 2023, the age-standardized mortality rate for asthma was lower than that of 1990 by 50.94%, whereas the 2023 rate for COPD was higher than the 1990 rate by 8.9%, according to data published in The Lancet Respiratory Medicine.The age-standardized mortality rate for ILD and pulmonary sarcoidosis also went up between 1990 and 2023, according to researchers.
    healio.com

    Higher rates of allergic rhinitis, food allergy found in congenital...

    The percentages of patients with allergic rhinitis, food allergy and allergic asthma were higher in those with congenital ichthyosis vs. the general population, according to data published in The Journal of Allergy and Clinical Immunology.Studied congenital ichthyosis types included lamellar ichthyosis, epidermolytic ichthyosis, congenital ichthyosiform erythroderma (CIE), X-linked ichthyosis,
    healio.com

    Survey: Public awareness of lung cancer screening low

    There is low public awareness of lung cancer screening and mortality, and many adults have not talked about their lung cancer risk with their doctor, according to survey results.These findings come from the American Lung Association’s Lung Health Barometer, a national survey conducted biennially, and in time for World Lung Cancer Day on Aug. 1.
    healio.com

    Access to blood-based lung cancer screening test raises screening r...

    ORLANDO — More patients in primary care practices with vs. without access to a blood-based lung cancer screening test received screening, according to findings presented at the American Thoracic Society International Conference.“It looks like access to this particular blood test does, in fact, increase lung cancer screening rates and increases them in a way that would be clinically
    healio.com

    FDA authorizes marketing of risk modification claim on Zyn nicotine...

    The FDA has authorized marketing of a risk modification claim on 20 Zyn nicotine pouch products that were authorized for sale in the U.S. last year.According to an FDA press release, marketing of these products can now include the modified risk claim that “using Zyn instead of cigarettes puts you at a lower risk of mouth cancer, heart disease, lung cancer, stroke, emphysema and chronic
    healio.com

    ‘It all flows together’: Ruchi Gupta, MD, MPH, balances many roles ...

    With roles as a clinician, professor, researcher, director and company founder, Ruchi Gupta, MD, MPH, has a lot to juggle — but she finds ways to blend them together.“I guess I get bored easily,” Gupta, founding director of the Center for Food Allergy & Asthma Research (CFAAR) and professor of pediatrics and medicine at Northwestern Feinberg School of Medicine,
    healio.com

    Monoclonal antibody lowers migraine days in adults with prior preve...

    In adults with prior preventive migraine treatment failures, an investigational monoclonal antibody led to larger decreases in monthly migraine days vs. placebo, according to a poster presented at a recent conference.Bocunebart (Lu AG09222, Lundbeck) is a monoclonal antibody that targets the pituitary adenylate cyclase-activating polypeptide (PACAP) ligand, according to the presentation at the
    healio.com

    Amateur soccer players see rise in neural damage blood biomarkers a...

    Amateur soccer players who headed the ball in a match vs. those who did not had significantly higher increases in S100B calcium-binding protein immediately after the match, according to results published in JAMA Neurology. “Soccer heading was associated with acute increases in blood biomarkers for neural damage, including dose-response relationships,” Marloes I. Hoppen, MSc, PhD candidate in
    healio.com

    Pooled phase 3 trials show reduced OSA severity with oral drug over...

    ORLANDO — Among adults with mild to severe obstructive sleep apnea, those receiving AD109, an oral combination drug, vs. placebo achieved lower disease severity at 26 weeks, according to pooled phase 3 trial results presented here.AD109 (Apnimed) is made up of 2.5 mg aroxybutynin, a novel antimuscarinic, and 75 mg atomoxetine, a selective norepinephrine reuptake inhibitor, according to a
    healio.com

    Control of positional OSA maintained in most 1 year after discontin...

    ORLANDO — Nearly 70% of patients with positional obstructive sleep apnea who discontinued positional therapy after achieving disease control still had control at 1 year, according to findings presented here.“These findings support a more personalized approach to OSA,” Irene Cano-Pumarega, MD, PhD, pneumonologist and head of the sleep unit at Ramn y Cajal Hospital in Madrid, told
    healio.com

    Q&A: Pilot study investigating metformin as food allergy treatment

    A pilot study, supported by the Food Allergy Fund, plans to assess metformin as a treatment in patients with peanut allergy.Notably, this effort is part of the Food Allergy Fund’s drug repurposing program.